Effects of clopidogrel on the rebound hypercoagulable state after heparin discontinuation in patients with acute coronary syndromes.
Di Nisio
Marcello
M
Bijsterveld
Nick R
NR
Meijers
Joost C M
JC
Levi
Marcel
M
Büller
Harry R
HR
Peters
Ron J G
RJ
D000208:Acute Disease; D000789:Angina, Unstable / Q000097:blood / Q000188:drug therapy*; D000925:Anticoagulants / Q000008:administration & dosage; D000990:Antithrombin III; D000077144:Clopidogrel; D006493:Heparin / Q000008:administration & dosage; D006801:Humans; D009203:Myocardial Infarction / Q000097:blood / Q000188:drug therapy*; D010446:Peptide Fragments / Q000097:blood; D010447:Peptide Hydrolases / Q000097:blood; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D011516:Prothrombin; D013577:Syndrome; D019851:Thrombophilia / Q000209:etiology; D013988:Ticlopidine / Q000031:analogs & derivatives* / Q000627:therapeutic use
D000925:Anticoagulants; D010446:Peptide Fragments; D010975:Platelet Aggregation Inhibitors; C046193:antithrombin III-protease complex; C045879:prothrombin fragment 1.2; D000990:Antithrombin III; D011516:Prothrombin; D006493:Heparin; D000077144:Clopidogrel; D010447:Peptide Hydrolases; D013988:Ticlopidine